Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akbar Pasha

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Development Research|January 31, 2025
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma CellsAkbar Pasha, Doneti Ravinder, Smita C Pawar
Scientific Reports|May 26, 2024
Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathwayAkbar Pasha, Kiran Kumar, S K Heena, et al.
Journal of Molecular Histology|April 2, 2025
Evaluating TGF-β1 gene expression and promoter polymorphism in cervical cancer progressionPavan Kumar Poleboyina, Akbar Pasha, S K Heena, et al.
Cytotechnology|January 27, 2025
Type IV collagen derived non-collagenous domain α6 (IV) NC1 and its derivative fragments inhibit endothelial cell proliferation and attenuates <i>in-vivo</i> chorioallantoic membrane angiogenesisAravind Setti, Akbar Pasha, Venkata Krishna Kanth Makani, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approachesDoneti Ravinder, Shailima Rampogu, Gangappa Dharmapuri, et al.
Applied Biochemistry and Biotechnology|April 22, 2023
Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic ApproachPavan Kumar Poleboyina, Manikandan Alagumuthu, Akbar Pasha, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|January 13, 2026
Assessment of circulating cell-free mitochondrial DNA as a damage associated molecular pattern in predicting severity and mortality of sepsis and septic shock patientsBushra, Safia Begum, Shaik Iqbal Ahmed, et al.
Medical Oncology (Northwood, London, England)|September 1, 2022
Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approachRavinder Doneti, Akbar Pasha, Mahendran Botlagunta, et al.
Applied Biochemistry and Biotechnology|July 1, 2023
Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-β1 Potential Inhibitors to Curtail Cervical Cancer ProgressionPavan Kumar Poleboyina, Umakanth Naik, Akbar Pasha, et al.
Biomed Research International|April 8, 2021
Identification of Differentially Expressed Genes in Cervical Cancer Patients by Comparative Transcriptome AnalysisAnnapurna S D, Deepthi Pasumarthi, Akbar Pasha, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Development Research|January 31, 2025
Andrographolide Mitigates Cisplatin Resistance by Inhibiting SPP1 Regulated NF-kB/iNOS/COX-2 and PI3K/AKT Pathway in Cisplatin Resistant Cervical Carcinoma CellsAkbar Pasha, Doneti Ravinder, Smita C Pawar
Scientific Reports|May 26, 2024
Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathwayAkbar Pasha, Kiran Kumar, S K Heena, et al.
Journal of Molecular Histology|April 2, 2025
Evaluating TGF-β1 gene expression and promoter polymorphism in cervical cancer progressionPavan Kumar Poleboyina, Akbar Pasha, S K Heena, et al.
Cytotechnology|January 27, 2025
Type IV collagen derived non-collagenous domain α6 (IV) NC1 and its derivative fragments inhibit endothelial cell proliferation and attenuates <i>in-vivo</i> chorioallantoic membrane angiogenesisAravind Setti, Akbar Pasha, Venkata Krishna Kanth Makani, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approachesDoneti Ravinder, Shailima Rampogu, Gangappa Dharmapuri, et al.
Applied Biochemistry and Biotechnology|April 22, 2023
Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic ApproachPavan Kumar Poleboyina, Manikandan Alagumuthu, Akbar Pasha, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|January 13, 2026
Assessment of circulating cell-free mitochondrial DNA as a damage associated molecular pattern in predicting severity and mortality of sepsis and septic shock patientsBushra, Safia Begum, Shaik Iqbal Ahmed, et al.
Medical Oncology (Northwood, London, England)|September 1, 2022
Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approachRavinder Doneti, Akbar Pasha, Mahendran Botlagunta, et al.
Applied Biochemistry and Biotechnology|July 1, 2023
Virtual Screening, Molecular Docking, and Dynamic Simulations Revealed TGF-β1 Potential Inhibitors to Curtail Cervical Cancer ProgressionPavan Kumar Poleboyina, Umakanth Naik, Akbar Pasha, et al.
Biomed Research International|April 8, 2021
Identification of Differentially Expressed Genes in Cervical Cancer Patients by Comparative Transcriptome AnalysisAnnapurna S D, Deepthi Pasumarthi, Akbar Pasha, et al.
Pageof 2